期刊文献+
共找到70篇文章
< 1 2 4 >
每页显示 20 50 100
Inferior vena cava obstruction and collateral circulation as unusual manifestations of hepatobiliary cystadenocarcinoma 被引量:10
1
作者 Nikolaos Arkadopoulos Anneza I Yiallourou +3 位作者 Constantinos Palialexis Emmanouil Stamatakis Evi Kairi-Vassilatou Vassilis Smyrniotis 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2013年第3期329-331,共3页
BACKGROUND: Hepatobiliary cystadenocarcinoma represents a rare epithelial malignant tumor derived from the intrahepatic bile duct. METHODS: A 71-year-old woman, who had undergone laparoscopic drainage of a cystic lesi... BACKGROUND: Hepatobiliary cystadenocarcinoma represents a rare epithelial malignant tumor derived from the intrahepatic bile duct. METHODS: A 71-year-old woman, who had undergone laparoscopic drainage of a cystic lesion of the right hepatic lobe, was misdiagnosed as having hepatic echinococcal disease, and received intracystic infusion of 95% ethanol four years ago. She was admitted to our hospital for further treatment. RESULTS: Physical examination revealed dilated superficial veins across the right abdominal wall. After mapping the direction of blood flow in these vessels, we assumed that this was a sign of inferior vena cava obstruction. Abdominal ultrasound, computed tomography, magnetic resonance imaging combined with magnetic resonance angiography showed a large cystic mass in the right upper quadrant and epigastrium, displacing the adjacent structures, adherent to the inferior vena cava, which was not patent, resulting in dilation of superficial epigastric veins. The patient underwent an exploratory laparotomy. Total excision of the huge mass measuring 16×15 cm was possible under selective vascular exclusion of the liver. Removal of the tumor resulted in immediate restoration of flow in the inferior vena cava. On the basis of the pathology and findings of immunohistochemical analysis, a hepatobiliary cystadenocarcinoma was diagnosed.CONCLUSIONS: In the present case, hepatobiliary cystadenocar-cinoma was accompanied by dilated superficial venous collaterals due to inferior vena cava obstruction. Selective vascular exclusion of the liver allowed a safe oncological resection of the tumor. 展开更多
关键词 hepatobiliary cystadenocarcinoma inferior vena cava obstruction collateral circulation
下载PDF
Liver cirrhosis in hepatic vena cava syndrome(or membranous obstruction of inferior vena cava) 被引量:8
2
作者 Santosh Man Shrestha 《World Journal of Hepatology》 CAS 2015年第6期874-884,共11页
Hepatic vena cava syndrome(HVCS) also known as membranous obstruction of inferior vena cava reported mainly from Asia and Africa is an important cause of hepatic venous outflow obstruction(HVOO) that is complicated by... Hepatic vena cava syndrome(HVCS) also known as membranous obstruction of inferior vena cava reported mainly from Asia and Africa is an important cause of hepatic venous outflow obstruction(HVOO) that is complicated by high incidence of liver cirrhosis(LC) and moderate to high incidence of hepatocellular carcinoma(HCC). In the past the disease was considered congenital and was included under Budd-Chiari syndrome(BCS). HVCS is a chronic disease common in developing countries, the onset of which is related to poor hygienic living condition. The initial lesion in the disease is a bacterial infection induced localized thrombophlebitis in hepatic portion of inferior vena cava at the site where hepatic veins open which on resolution transforms into stenosis, membrane or thick obstruction,and is followed by development of cavo-caval collateral anastomosis. The disease is characterized by long asymptomatic period and recurrent acute exacerbations(AE) precipitated by clinical or subclinical bacterial infection. AE is managed with prolonged oral antibiotic. Development of LC and HCC in HVCS is related to the severity and frequency of AEs and not to the duration of the disease or the type or severity of the caval obstruction. HVOO that develops during severe acute stage or AE is a pre-cirrhotic condition. Primary BCS on the other hand is a rare disease related to prothrombotic disorders reported mainly among Caucasians that clinically manifest as acute, subacute disease or as fulminant hepatic failure; and is managed with life-long anticoagulation, portosystemic shunt/endovascular angioplasty and stent or liver transplantation. As epidemiology, etiology and natural history of HVCS are different from classical BCS, it is here, recognized as a separate disease entity, a third primary cause of HVOO after sinusoidal obstruction syndrome and BCS. Understanding of the natural history has made early diagnosis of HVCS possible. This paper describes epidemiology, natural history and diagnosis of HVCS and discusses the pathogenesis of LC in the disease and mentions distinctive clinical features of HVCS related LC. 展开更多
关键词 Hepatic venous outflow obstruction Budd-Chiari syndrome Hepatic inferior vena cava disease Bacterial infection Hepatocellular carcinoma
下载PDF
Retroperitoneal hematoma after implantation of double inferior vena cava filters 被引量:5
3
作者 Yulong Tian Hongshan Zhong Wei Zhang 《Journal of Interventional Medicine》 2018年第4期252-256,共5页
A 55-year-old man developed deep venous thrombosis and inferior vena cava(IVC) thrombosis 7 years earlier and was treated by placement of a permanent IVC filter. One week ago, he was admitted with bilateral lower limb... A 55-year-old man developed deep venous thrombosis and inferior vena cava(IVC) thrombosis 7 years earlier and was treated by placement of a permanent IVC filter. One week ago, he was admitted with bilateral lower limb swelling and pain. Digital subtraction angiography showed a filling defect above the original filter. A retrievable Tulip filter was placed and catheter-directed thrombolysis was performed. Six days later, the patient experienced sudden, persistent upper right abdominal pain, and a computed tomography scan revealed the formation of retroperitoneal hematoma. Symptomatic treatments were administered, and the hematoma gradually resolved during follow-up. 展开更多
关键词 ivc RETROPERITONEAL HEMATOMA AFTER IMPLANTATION of DOUBLE inferior vena cava filters Figure
下载PDF
Utility of the Inferior Vena Cava Diameter as a Marker of Dry Weight in Nonoliguric Hemodialyzed Patients
4
作者 SATORUYANAGIBA YASUHIROYNDO +1 位作者 EIJIKUSANO YASUSHIASANO 《中国血液净化》 2002年第8期1-6,共6页
  We have previously reported that the maximal inferior vena cava(IVC) diameter during quiet expiration(IVCe) measured by ultrasonography correlates well with the amount of body fluid, especially the circulating blo...   We have previously reported that the maximal inferior vena cava(IVC) diameter during quiet expiration(IVCe) measured by ultrasonography correlates well with the amount of body fluid, especially the circulating blood volume[1] and proposed using the criteria of IVC diameter to determine dry weight(DW) in anuric hemodialyzed (HD) patients: standard IVCe of pre-and post-HD are (14.9±0.4) and (8.2±0.3) mm, respectively[2]. However, the same post-HD IVC criterion should not be applied to nonoliguric HD patients because it could result in rapid deterioration of residual renal function due to forced dehydration. Although the biochemical DW marker plasma atrial natriuretic peptide (ANP) is useful to evaluate hypervolemia but not hypovolemia,both hyper-and hypovolemia can be detected by IVC measurement.…… 展开更多
关键词 HD Utility of the inferior vena cava Diameter as a Marker of Dry Weight in Nonoliguric Hemodialyzed Patients CRF ivc
下载PDF
The Inferior Vena Cava Diameter as a Marker of Dry Weight in Chronic Hemodialyzed Patients(续)
5
作者 Yasuhiro Ando Satoru Yanagiba Yasushi Asano 《中国血液净化》 2002年第10期1-4,共4页
  The IVC diameters in HD patients   Since BW and stature as well as gender and age were not considered to be determinant factors of the IVC diameters, these factors were not accounted for in evaluating the IVC d...   The IVC diameters in HD patients   Since BW and stature as well as gender and age were not considered to be determinant factors of the IVC diameters, these factors were not accounted for in evaluating the IVC diameters in HD patients. The IVC diameters of stable anuric HD patients are shown in Table 2. In agreement with our previous observation [7-9] ,the reduction of BW from (51.7±12.6) to (49.3±12.6)kg by ultrafiltration during HD resulted in a significant (P<0.0001)reduction of the IVCe and IVCi from (14.9 ± 3.2) to (6.8±1.9)mm and (5.2±4.2) to (0.1±0.3) mm,respectively. Thus,CI values before and at the end of HD were calculated as (0.68±0.24) and (0.98±0. 05), respectively (P<0.0001).   …… 展开更多
关键词 ivc The inferior vena cava Diameter as a Marker of Dry Weight in Chronic Hemodialyzed Patients
下载PDF
IVC-RVI联合血清炎症因子水平预测脓毒症休克患者容量反应性的价值 被引量:4
6
作者 蔺伟 陈琳琳 宋彩霞 《中国急救复苏与灾害医学杂志》 2023年第1期78-81,共4页
目的 探讨下腔静脉内径呼吸变异度(IVC-RVI)联合血清炎症因子水平预测脓毒症休克患者容量反应性的临床价值。方法 选取锦州市中心医院2019年6月—2021年6月120例脓毒症休克患者作为研究对象,根据容量负荷试验将患者分为有反应组(n=52)... 目的 探讨下腔静脉内径呼吸变异度(IVC-RVI)联合血清炎症因子水平预测脓毒症休克患者容量反应性的临床价值。方法 选取锦州市中心医院2019年6月—2021年6月120例脓毒症休克患者作为研究对象,根据容量负荷试验将患者分为有反应组(n=52)和无反应组(n=68)。于容量负荷试验前采用超声测定患者吸气末下腔静脉最大内径(D_(max))、呼气末下腔静脉最小内径(D_(min)),计算IVC-RVI。于患者入院时测定血清炎症因子[白介素-6(IL-6)、C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)]。借助ROC分析D_(max)、D_(min)、IVC-RVI、IL-6、CRP、TNF-α对脓毒症休克患者有容量反应性的预测价值,通过一致性分析,评估D_(max)、D_(min)、IVC-RVI联合IL-6、CRP、TNF-α对脓毒症休克患者有容量反应性的预测价值。结果 有反应组D_(max)、D_(min)显著低于无反应组,IVC-RVI显著高于无反应组,比较差异有统计学意义(P<0.05)。有反应组血清IL-6、CRP、TNF-α水平均显著低于无反应组,比较差异有统计学意义(P<0.05)。经ROC分析,D_(_(max))、D_(min)、IVC-RVI、IL-6、CRP、TNF-α预测脓毒症休克患者有容量反应性的曲线下面积分别为0.836、0.846、0.804、0.903、0.877、0.756,均有P<0.05。经一致性分析,120例脓毒症休克患者中联合预测阳性51例,敏感度为0.981,特异性为0.971,准确率为0.975,Kappa为0.949。结论 IVC-RVI和血清炎症因子水平均可用于脓毒症休克患者容量反应性预测中,且联合检测可获得更好的敏感度、特异性。 展开更多
关键词 下腔静脉内径呼吸变异度 炎症因子 脓毒症休克 容量反应性
下载PDF
Insights into treatment for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium
7
作者 Jia Yang Yongjie Shui +2 位作者 Lihong Liu Genhua Yu Qichun Wei 《Hepatobiliary Surgery and Nutrition》 SCIE 2024年第1期168-171,共4页
Hepatocellular carcinoma(HCC),one of the most common liver cancers,often has a poor prognosis when it involves macrovascular invasion.Oncological emergencies including pulmonary embolism,heart failure,and even sudden ... Hepatocellular carcinoma(HCC),one of the most common liver cancers,often has a poor prognosis when it involves macrovascular invasion.Oncological emergencies including pulmonary embolism,heart failure,and even sudden death could happen when it develops a tumor thrombus(TT)in the inferior vena cava(IVC)or right atrium(RA),indicating an exceptionally grim prognosis(1).Although systemic therapy is the only standard treatment recommended by guidelines(2),other treatment modalities are explored including surgery,radiotherapy,etc.in some centers.Surgery,as the only potential curative treatment,has been explored in several selected cases.A case of long-term survival of 15 years and cancer-free survival of 9 years was reported by surgical resection with a heart-first approach under cardiopulmonary bypass(CPB)(3),suggesting that aggressive surgery together with multidisciplinary treatments might achieve long survival.However,due to the aggressiveness and challenge of surgical resection-massive resection area,potential significant blood loss,and bypass needed,surgical resection is applied in very limited centers.Nevertheless,safety,efficacy,and long-term survival benefits for these patients are poorly investigated. 展开更多
关键词 Hepatocellular carcinoma(HCC) inferior vena cava(ivc) right atrium(RA) tumor thrombus(TT)
原文传递
Fracture Rate and Serious Complications of Vena Cava Filters 被引量:1
8
作者 Myles M. Mitsunaga Hyo-Chun Yoon 《Open Journal of Radiology》 2013年第2期85-90,共6页
Purpose: To retrospectively evaluate the prevalence of fracture and fragment embolization of inferior vena cava (IVC) filters. Methods: Electronic medical records and imaging studies of all Kaiser Permanente patients ... Purpose: To retrospectively evaluate the prevalence of fracture and fragment embolization of inferior vena cava (IVC) filters. Methods: Electronic medical records and imaging studies of all Kaiser Permanente patients who received IVC filters from August 2000 until August 2010 were retrospectively reviewed for filter complications. Results: 283 patients received an IVC filter during the study period. 143 patients were deceased, while 140 are living. Among deceased patients, the average age at the time of death was 69.8 ± 15.3 [range: 24.7 - 99.2] years;55.9% were men;the mean implantation-to-image time was 13.6 ± 20.6 [range: 0 - 92.4] months, and there were no reported major complications attributable to filter migration or fracture at a mean of 16.8 ± 24.8 [range: 0 - 119.6] months following implantation. One of 14 (7.1%) G2 filters perforated the aorta, which already had a stent graft in place. Among those patients still living, the average age was 67.3 ± 15.2 [range: 15.2 - 97.3] years, 47.1% were men, the mean implantation-to-image time was 33.3 ± 36.5 [range: 0.1-141.7] months, and there were no reported major complications at a mean of 35.3 ± 36.5 [range: 0 - 141.7] months following implantation. Three of 60 (5.0%) Trapease filters were found to have at least 1 strut fracture. There were no cases of filter migration or fragment embolization. The overall fracture rate of all filters with an implantation-to-image-time greater than two years (mean implantation-to-image time 4.7 ± 2.7 [range: 2.0 - 11.8] years) was 3 of 67 (4.5%). Bard G2 and G2X filters had a 0% fracture and embolization rate at a mean of 19.0 ± 16.6 [range: 0.07 - 49.5] months after implantation. Conclusions: IVC filters, regardless of type, have a low prevalence of fracture and we found no cases of fragment embolization. 展开更多
关键词 VENOUS THROMBOEMBOLISM inferior vena cava ivc Filters Pulmonary EMBOLISM Deep VENOUS THROMBOSIS Complications
下载PDF
Fatal thrombotic complications of hepatic cystic compression of the inferior vena: A case report
9
作者 Ting-Kai Leung Chi-Ming Lee Hsin-Chi Chen 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第11期1728-1729,共2页
Of 5% of patients who develop liver cysts, only 10-15%of them come for medical attention, typically because of dull right upper quadrant pain, abdominal bloating or early satiety. We treated a 77-year-old female with ... Of 5% of patients who develop liver cysts, only 10-15%of them come for medical attention, typically because of dull right upper quadrant pain, abdominal bloating or early satiety. We treated a 77-year-old female with a rare complication of inferior vena cava thrombosis. The patient expired due to septic shock and multiple organ failure. 展开更多
关键词 Liver cyst inferior vena cava thrombosis Non-parasitic cyst CELLULITIS ivc compression Sepsis
下载PDF
植入放射性支架联合经动脉化疗栓塞(TACE)治疗肝恶性肿瘤合并下腔静脉(IVC)梗阻 被引量:6
10
作者 杨清慧 张雯 +4 位作者 颜志平 罗剑均 刘凌晓 杨敏捷 刘清欣 《复旦学报(医学版)》 CAS CSCD 北大核心 2014年第5期617-623,共7页
目的探讨植入携带粒子条支架及经动脉化疗栓塞(transarterial chemoembolization,TAcE)联合治疗肝恶性肿瘤伴下腔静脉(inferior vena CaV&,IvC)梗阻的安全性及疗效。方法对2008年7月至2013年6月共97例在我院接受介入治疗的肝恶性... 目的探讨植入携带粒子条支架及经动脉化疗栓塞(transarterial chemoembolization,TAcE)联合治疗肝恶性肿瘤伴下腔静脉(inferior vena CaV&,IvC)梗阻的安全性及疗效。方法对2008年7月至2013年6月共97例在我院接受介入治疗的肝恶性肿瘤伴下腔静脉梗阻患者的资料进行回顾性分析。在所有患者下腔静脉梗阻段植入携带粒子条支架,同时对肝内病灶进行化疗栓塞治疗。对下腔静脉症状缓解率、支架通畅性、生存期及预后因素进行分析。结果下腔静脉支架及粒子条植入手术成功率为100%;IVC支架通畅率为98%,下腔静脉梗阻症状缓解率为98%;患者平均生存时间为(277.6±251.4)天,中位生存期为(203.0±251.3)天;在随访期2~36个月期间支架通畅率为98%。结论植入携带粒子条支架联合经动脉化疗栓塞治疗肝恶性肿瘤伴下腔静脉梗阻患者安全可行,疗效好。 展开更多
关键词 ^125I粒子 肝细胞肝癌 下腔静脉 近距离放疗 经动脉化疗栓塞(TACE)
下载PDF
恶性肿瘤合并下腔静脉(IVC)栓子行栓子活检术的临床意义 被引量:2
11
作者 方主亭 颜志平 +7 位作者 罗剑钧 张雯 吴林霖 刘清欣 瞿旭东 王建华 王小林 刘凌晓 《复旦学报(医学版)》 CAS CSCD 北大核心 2012年第4期395-399,共5页
目的评价对恶性肿瘤合并下腔静脉(inferior vena cava,IVC)栓子患者行栓子活检术的临床意义。方法对14例恶性肿瘤合并IVC栓子患者经右侧股静脉行IVC栓子活检。记录取出标本的成功率和患者术中及术后的不良反应或并发症,并随访2个月了解... 目的评价对恶性肿瘤合并下腔静脉(inferior vena cava,IVC)栓子患者行栓子活检术的临床意义。方法对14例恶性肿瘤合并IVC栓子患者经右侧股静脉行IVC栓子活检。记录取出标本的成功率和患者术中及术后的不良反应或并发症,并随访2个月了解是否引起医源性肺部转移。分析病理结果,与术前CT或MRI诊断进行比较,判断影像诊断的准确率。结果 IVC栓子活检术成功率为100%,患者术中及术后未出现急性肺栓塞(pulmonary embolism,PE)及IVC破裂出血,随访2个月未发现医源性肺转移。术前影像学诊断与病理结果的符合率较高,达93%。结论恶性肿瘤合并IVC栓子行栓子活检术是安全、微创、易行的,能为进一步治疗提供病理学依据。 展开更多
关键词 恶性肿瘤 下腔静脉(ivc) 瘤栓 活检
下载PDF
Vascular complications of liver abscess: A literature review
12
作者 Rahul Arya Ramesh Kumar +2 位作者 Rajeev N Priyadarshi Ruchika Narayan Utpal Anand 《World Journal of Meta-Analysis》 2024年第3期17-29,共13页
Extensive vascular network and proximity to the gastrointestinal tract make the liver susceptible to abscess formation.While pyogenic liver abscesses account for the majority of liver abscesses in the Western world,am... Extensive vascular network and proximity to the gastrointestinal tract make the liver susceptible to abscess formation.While pyogenic liver abscesses account for the majority of liver abscesses in the Western world,amebic liver abscesses are more prevalent in tropical and developing nations.Most liver abscesses heal without complications.However,various vascular complications can occur in these patients,including compression of the inferior vena cava,thrombosis of the portal vein and/or hepatic veins,hepatic artery pseudoaneurysm,direct rupture into major vessels or the pericardium,and biliovascular fistula.These compli-cations can present significant clinical challenges due to the potential for hae-morrhage,ischemia,and systemic embolism,thereby increasing the risk of morbidity and mortality.Mechanical compression,flow stasis,inflammation,endothelial injury,and direct invasion are some of the proposed mechanisms that can cause vascular complications in the setting of a liver abscess.For the diag-nosis,thorough assessment,and therapeutic planning of vascular complications,more sophisticated imaging techniques such as multidetector computed tomo-graphy angiography or magnetic resonance angiography may be necessary.Although most vascular complications resolve with abscess treatment alone,additional interventions may be required based on the nature,severity,and course of the complications.This article aims to provide a systematic update on the spectrum of vascular complications of liver abscesses,offering insights into their pathogenesis,diagnosis,and management strategies. 展开更多
关键词 Liver abscess PYLEPHLEBITIS Venous thrombosis PSEUDOANEURYSM Portal cavernoma inferior vena cava obstruction
下载PDF
Digital radiograph(DR)guided bedside IVC filter placements in patients with intracranial pressure monitors 被引量:3
13
作者 Arthur S.Joseph Jorge E.Lopera 《Journal of Interventional Medicine》 2021年第4期208-211,共4页
Purpose:The purpose of this study is to report a single center experience with portable digital radiographically(DR)guided bedside IVC filters placed in intensive care unit(ICU)patients with high ICP and elevated head... Purpose:The purpose of this study is to report a single center experience with portable digital radiographically(DR)guided bedside IVC filters placed in intensive care unit(ICU)patients with high ICP and elevated head of bed(HOB).Materials and methods:A retrospective chart review was conducted on all bedside IVC filters placed from January 1,2010 to September 16,2020.Patients with high ICP and elevated head of bed requirements were included.Charts were reviewed for filter type,common femoral vein(CFV)access,filter location,pre procedure imaging,pre and post filter ICPs,glascow coma scale,number of radiographs taken,and filter removal.ICPs were obtained 1 h prior to procedure and 2 h post procedure and analyzed with a paired T test.Filters were placed by reviewing prior CT scan for IVC size,caval variants,renal and iliac veins and vertebral body landmarks.Then,CFV access was obtained and a Bentson wire was advanced 30-40 cm.A radiograph was used to confirm adequate position of the of the wire.The filter sheath was advanced and serial radiographs were used to position the filter sheath at the final predetermined position below the renal veins and above the iliac bifurcation.The filter was deployed,and a radiograph was obtained to confirm filter positioning.Results:A total of 9 DR guided bedside IVC filters were placed(4 Denali,3 Option Elite,2 Celect).Indications included prophylactic placement(n=8)and acute DVT(n=1).The average patient age was 35.8 years(range:18-56 years)CT abdomen and pelvis was used to assess for the level of renal veins in all patients(n=9).No caval variants were encountered on pre-procedural planning.The average pre,intraprocedural,and post procedure intracranial pressure was 16 mmHg,13 mmHg,and 16 mmHg,respectively.Confirmation of placement after final placement was available in 7 patients(4 DR,2 CT and one fluoroscopic examination).Two non-procedural related deaths occurred.Technical success,defined as successful placement of IVC filter at the predetermined level,was achieved in 100%of patients(n=9).The right CFV was used in most patients(n=7).The left CFV was used for access in two patients due to right CFV thrombus(n=1)and existing right femoral venous central line(n=1).The average number of radiographs taken was 5.8(range 4-9).In all cases,filters were placed below the level of the lowest renal vein(n=9).A comparison of pre,during and post intervention ICP pressures is shown in table,2.No differences between pre and post filter ICP was noted(p=0.77).Three filters were later removed.One minor complication was reported,which was filter tilt(23%)in an Option filter.Conclusion:Bedside IVC filters can be safely placed in patients with head trauma and high ICP who are unable to lay supine using portable DR guidance with a high rate of technical success and minimal complications. 展开更多
关键词 ivc Filter PROPHYLACTIC inferior vena cava THROMBUS
下载PDF
下肢深静脉血栓患者下腔静脉滤器置入术后发生静脉不畅的影响因素 被引量:3
14
作者 刘振华 赵振蓓 《中国民康医学》 2023年第6期13-15,共3页
目的:探讨下肢深静脉血栓(DVT)患者下腔静脉滤器(IVCF)置入术后发生静脉不畅的影响因素。方法:回顾性分析2020年3月至2022年4月该院收治的70例下肢DVT患者的临床资料,患者均行IVCF置入术治疗,术后3个月复查,根据静脉通畅程度将其分为静... 目的:探讨下肢深静脉血栓(DVT)患者下腔静脉滤器(IVCF)置入术后发生静脉不畅的影响因素。方法:回顾性分析2020年3月至2022年4月该院收治的70例下肢DVT患者的临床资料,患者均行IVCF置入术治疗,术后3个月复查,根据静脉通畅程度将其分为静脉通畅组32例和静脉不畅组38例。收集患者的临床资料,采用单因素和多因素Logistic回归分析下肢DVT患者IVCF置入术后发生静脉不畅的影响因素。结果:两组性别、年龄、体质量指数、DVT分期、D-二聚体水平比较,差异均无统计学意义(P>0.05);静脉不畅组合并糖尿病、高血压占比和白细胞计数(WBC)、血小板计数(PLT)、纤维蛋白原(FIB)水平均高于静脉通畅组,差异有统计学意义(P<0.05);Logistic回归分析结果显示,合并糖尿病、高血压和WBC、PLT、FIB水平升高均为下肢DVT患者IVCF置入术后发生静脉不畅的危险因素(P<0.05)。结论:合并糖尿病、高血压和WBC、PLT、FIB水平升高均为下肢DVT患者IVCF置入术后发生静脉不畅的危险因素,临床可针对上述危险因素实施针对性干预措施,以改善预后。 展开更多
关键词 下肢 深静脉血栓 下腔静脉滤器置入术 静脉不畅 影响因素 糖尿病 高血压 白细胞计数
下载PDF
超声监测下腔静脉扩张指数联合肺部超声在AECOPD合并脓毒症机械通气治疗中的应用价值分析
15
作者 史为涛 王旭东 +1 位作者 刘雅文 姜维 《中国实用医药》 2023年第24期46-50,共5页
目的探讨超声监测下腔静脉扩张指数(IVC-DI)联合肺部超声(LU)在慢性阻塞性肺疾病急性加重期(AECOPD)合并脓毒症需行机械通气治疗患者中的临床应用价值。方法92例AECOPD合并脓毒症接受机械通气治疗患者,采用随机数字表法分为CVP组(31例)... 目的探讨超声监测下腔静脉扩张指数(IVC-DI)联合肺部超声(LU)在慢性阻塞性肺疾病急性加重期(AECOPD)合并脓毒症需行机械通气治疗患者中的临床应用价值。方法92例AECOPD合并脓毒症接受机械通气治疗患者,采用随机数字表法分为CVP组(31例)、CVP-IVC组(31例)和IVC-LU组(30例)。CVP组通过监测中心静脉压(CVP)指导液体治疗,CVP-IVC组依据CVP和IVC-DI指导液体治疗,IVC-LU组依据IVC-DI和LU指导液体治疗。比较三组患者的液体治疗量、呼吸力学参数[气道平台压(Pplat)、肺静态顺应性(Cst)]、氧合指数(OI)、炎症指标[C反应蛋白(CRP)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)]及临床预后指标[急性生理功能和慢性健康状况评分系统Ⅱ(APACHEⅡ)评分、机械通气时间、入住重症加强护理病房(ICU)时间及肾脏替代治疗率]。结果第3个24 h,IVC-LU组的液体治疗量低于CVP组(P<0.05);第4、5个24 h,IVC-LU组的液体治疗量低于CVP组和CVP-IVC组(P<0.05)。第3个24 h,IVC-LU组的Pplat低于CVP组,Cst高于CVP组(P<0.05);第5个24 h,IVC-LU组的Pplat低于CVP组和CVP-IVC组,Cst及OI高于CVP组和CVP-IVC组(P<0.05)。第3个24 h,IVC-LU组IL-6水平低于CVP组(P<0.05);第5个24 h,IVC-LU组CRP、IL-6和IL-1β水平低于CVP组和CVP-IVC组(P<0.05)。IVC-LU组的APACHEⅡ评分(15.17±2.11)分低于CVP组的(17.46±2.34)分和CVP-IVC组的(17.16±2.58)分(P<0.05);IVC-LU组肾脏替代治疗率低于CVP组和CVP-IVC组,但差异无统计学意义(P>0.05);IVC-LU组的机械通气时间、ICU住院时间短于CVP组和CVP-IVC组(P<0.05)。结论超声监测IVC-DI评估容量联合LU评估血管外肺水指导接受机械通气的AECOPD合并脓毒症患者的液体治疗,可准确评估所需液量,限制过量输液,提高Cst和OI,减少炎症因子释放,缩短机械通气时间和ICU住院时间。 展开更多
关键词 下腔静脉扩张指数 肺部超声 慢性阻塞性肺疾病急性加重期 脓毒症 液体治疗
下载PDF
下腔静脉隔膜阻塞型布-加综合征的病理学及病因学研究 被引量:35
16
作者 王佾 张辉 +1 位作者 郭成浩 樊庆勇 《介入放射学杂志》 CSCD 2008年第7期500-503,共4页
目的研究下腔静脉隔膜阻塞型布-加综合征(BCS)的解剖位置和隔膜病理特点,以探讨病因及发病机制。方法分析100例非BCS死亡成人解剖资料,进行下腔静脉膈肌以上至右心房的大体观察。常规显微镜病理检查70例下腔静脉隔膜阻塞型患者的隔膜活... 目的研究下腔静脉隔膜阻塞型布-加综合征(BCS)的解剖位置和隔膜病理特点,以探讨病因及发病机制。方法分析100例非BCS死亡成人解剖资料,进行下腔静脉膈肌以上至右心房的大体观察。常规显微镜病理检查70例下腔静脉隔膜阻塞型患者的隔膜活检材料及20例BCS患者根治术后切除的完整隔膜。结果大体观察发现1例(1%)在位于平膈肌水平距下腔静脉入右心房28mm处、肝静脉开口上方的左外侧壁,存在一瓣膜;47%成人位于下腔静脉近右心房口存在Eustachian瓣。镜检显示,上述全部隔膜符合血管瓣膜样结构。其中30%(21/70)样本附有机化血栓。9%(6/70)样本内有少量炎细胞浸润。全部完整隔膜病理检查与血管壁相延续。结论首次报道在位于下腔静脉平膈肌水平有一瓣膜,这一瓣膜的发现,可能与下腔静脉隔膜阻塞型BCS的发生高度相关。 展开更多
关键词 瓣膜 Eustachian瓣 下腔静脉隔膜阻塞 布加综合征 下腔静脉 病理学 病因学
下载PDF
布-加综合征合并肝癌36例临床分析 被引量:11
17
作者 韩新强 祖茂衡 +3 位作者 顾玉明 徐浩 许伟 王文亮 《介入放射学杂志》 CSCD 北大核心 2011年第3期207-209,共3页
目的探讨布-加综合征(BCS)合并肝癌(HCC)的临床特征及相关因素,从而提供治疗思路。方法回顾性分析1994年6月-2010年7月收治的1240例BCS患者中合并HCC者36例,对其影像学、实验室检查及治疗后转归进行分析。结果 BCS合并HCC主要发生在下... 目的探讨布-加综合征(BCS)合并肝癌(HCC)的临床特征及相关因素,从而提供治疗思路。方法回顾性分析1994年6月-2010年7月收治的1240例BCS患者中合并HCC者36例,对其影像学、实验室检查及治疗后转归进行分析。结果 BCS合并HCC主要发生在下腔静脉膜性阻塞病变中(33/36),发病平均年龄47岁,术后生存时间为14~62个月,平均生存期为32.5个月;完成随访的30例中8例BCS术后发生HCC者生存时间为BCS术后18~62个月,平均37个月;22例BCS术前诊断合并HCC者有效生存时间为BCS术后14~56个月,平均30.8个月。结论对于BCS合并HCC者应先行肿瘤TACE或TAI治疗再行BCS介入治疗。 展开更多
关键词 布-加综合征 肝癌 下腔静脉 膜性阻塞
下载PDF
球囊扩张辅助经导管直接溶栓导致下腔静脉滤器栓塞及其处理 被引量:15
18
作者 郝红军 李智 +1 位作者 金泳海 倪才方 《介入放射学杂志》 CSCD 北大核心 2012年第6期461-464,共4页
目的探讨球囊扩张辅助经导管直接溶栓(CDT)治疗急性下肢深静脉血栓形成(DVT)过程中下腔静脉滤器(VCF)血栓阻塞的发生率及其处理。方法 2009年9月至201 1年5月收治44例急性下肢DVT患者,作下腔静脉VCF保护下行球囊扩张辅助CDT治疗。结果 2... 目的探讨球囊扩张辅助经导管直接溶栓(CDT)治疗急性下肢深静脉血栓形成(DVT)过程中下腔静脉滤器(VCF)血栓阻塞的发生率及其处理。方法 2009年9月至201 1年5月收治44例急性下肢DVT患者,作下腔静脉VCF保护下行球囊扩张辅助CDT治疗。结果 27.3%(12/44)患者因VCF拦截大量血栓导致下腔静脉阻塞(完全闭塞8例,部分闭塞4例),经CDT治疗后1 1例完全通畅,1例部分通畅(造影表现为VCF远端充盈缺损)。治疗前后下腔静脉通畅度评分差异有统计学意义(X^2=48.2,P=0.000)。88.64%(39/44)的患者放置可取出VCF,治疗结束后均全部顺利取出。主要并发症包括穿刺点出血13.6%(6/44)、肉限血尿4.5%(2/44)、痰中带血4.5%(2/44),未发生症状性肺栓塞。结论球囊扩张辅助CDT治疗急性下肢DVT可能发生血栓脱落,由此导致的急性VCF血栓阻塞经CDT治疗效果良好。 展开更多
关键词 下肢深静脉血栓形成 导管溶栓 腔静脉滤器 下腔静脉阻塞综合征
下载PDF
下腔静脉指标评估脓毒症休克患者容量反应性的可靠性再思考 被引量:10
19
作者 赵浩天 龙玲 +1 位作者 任珊 赵鹤龄 《中国急救医学》 CAS CSCD 北大核心 2020年第8期763-767,共5页
尽管脓毒症休克指南推荐在应用血管活性药物前应充分液体复苏.然而“充分”不等于“大量”,对脓毒症休克患者过度容量复苏会造成肺水肿、急性肾损伤等多器官损害.准确评估容量反应性是液体复苏前的必要措施.床旁经胸超声监测下腔静脉(I... 尽管脓毒症休克指南推荐在应用血管活性药物前应充分液体复苏.然而“充分”不等于“大量”,对脓毒症休克患者过度容量复苏会造成肺水肿、急性肾损伤等多器官损害.准确评估容量反应性是液体复苏前的必要措施.床旁经胸超声监测下腔静脉(IVC)成为重症监护病房(ICU)必备的容量状态评估利器.然而近年来许多研究发现,IVC径线变化除受容量负荷影响外,还受机械通气(MV)模式、心功能状态、腹腔内压等诸多因素影响,其准确性受到诸多学者质疑.本文就IVC评估容量反应性的原理、适用条件及新进展进行综述,以期明确其适应范围,提高其预测准确性. 展开更多
关键词 容量反应性 下腔静脉(ivc) 脓毒症休克 机械通气(MV)
下载PDF
内支架置入对不同类型下腔静恶性梗阻的临床价值 被引量:7
20
作者 沈杰 王成刚 +1 位作者 马爱英 王良文 《介入放射学杂志》 CSCD 2008年第7期493-496,共4页
目的评价内支架置入对不同类型下腔静脉(IVC)恶性梗阻的临床价值。方法84例肝癌伴IVC梗阻患者经MRA和(或)DSA检查,分为外压型和栓塞型IVC梗阻。其中,47例外压型IVC梗阻分为支架置入组26例(A组)和对照组21例(B组);37例栓塞型IVC梗阻分为... 目的评价内支架置入对不同类型下腔静脉(IVC)恶性梗阻的临床价值。方法84例肝癌伴IVC梗阻患者经MRA和(或)DSA检查,分为外压型和栓塞型IVC梗阻。其中,47例外压型IVC梗阻分为支架置入组26例(A组)和对照组21例(B组);37例栓塞型IVC梗阻分为支架置入组20例(C组)和对照组17例(D组)。有适应证患者,均行肝动脉化疗栓塞(TACE)。结果经治疗后,A组和C组患者近期(1周内)梗阻症状缓解率分别为96.2%和90.0%(P>0.05);中期(6周后)梗阻症状缓解率分别为84.6%和30.0%(P<0.05);支架内再梗阻率分别为30.8%和75.0%(P<0.05)。A组和B组患者中位生存期分别为300d和120d(P<0.05)。C组和D组患者中位生存期分别为67d和55d(P>0.05)。结论对于外压型IVC梗阻,置入内支架能显著改善患者梗阻症状,延长生存期,主张积极施行内支架置入术;对于栓塞型IVC梗阻,置入内支架后发生再梗阻率较高,并不能延长生存期,可作为一种有限的姑息性治疗手段。 展开更多
关键词 下腔静脉 梗阻 外压 栓塞 支架
下载PDF
上一页 1 2 4 下一页 到第
使用帮助 返回顶部